SELLAS Life Sciences Group annual ebitda
2011
2012
2013
2014
2015
2016
SELLAS Life Sciences Group EBITDA Growth & History (SLS)
SELLAS Life Sciences Group's calculated EBITDA was −$16.0M for fiscal 2016.
View full SELLAS Life Sciences Group company overviewSELLAS Life Sciences Group annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2016 | 2016-12-31 | −$16.0M | $18.1M | — |
| 2015 | 2015-12-31 | −$34.1M | $9.7M | — |
| 2014 | 2014-12-31 | −$43.8M | −$15.6M | — |
| 2013 | 2013-12-31 | −$28.2M | −$7.1M | — |
| 2012 | 2012-12-31 | −$21.1M | −$8.8M | — |
| 2011 | 2011-12-31 | −$12.3M | — | — |
SELLAS Life Sciences Group quarterly ebitda
Q2.11
Q3.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q3 2017 | 2017-09-30 | −$4.4M | $2.0M | — |
| Q2 2017 | 2017-06-30 | −$4.9M | $4.3M | — |
| Q1 2017 | 2017-03-31 | −$5.1M | $3.9M | — |
| Q4 2016 | 2016-12-31 | $8.7M | $16.4M | — |
| Q3 2016 | 2016-09-30 | −$6.4M | $2.1M | — |
| Q2 2016 | 2016-06-30 | −$9.2M | −$233,000 | — |
| Q1 2016 | 2016-03-31 | −$9.0M | −$148,000 | — |
| Q4 2015 | 2015-12-31 | −$7.8M | −$1.8M | — |
| Q3 2015 | 2015-09-30 | −$8.5M | $2.2M | — |
| Q2 2015 | 2015-06-30 | −$9.0M | $6.6M | — |
| Q1 2015 | 2015-03-31 | −$8.8M | $2.8M | — |
| Q4 2014 | 2014-12-31 | −$6.0M | $926,000 | — |
| Q3 2014 | 2014-09-30 | −$10.7M | −$3.9M | — |
| Q2 2014 | 2014-06-30 | −$15.6M | −$7.6M | — |
| Q1 2014 | 2014-03-31 | −$11.6M | −$5.0M | — |
| Q4 2013 | 2013-12-31 | −$6.9M | −$1.4M | — |
| Q3 2013 | 2013-09-30 | −$6.8M | −$2.2M | — |
| Q2 2013 | 2013-06-30 | −$7.9M | — | — |
| Q1 2013 | 2013-03-31 | −$6.6M | — | — |
| Q3 2012 | 2012-09-30 | −$5.5M | — | — |
| Q2 2011 | 2011-06-30 | −$4.6M | — | — |
SELLAS Life Sciences Group ebitda trends
Over the last five reported fiscal years, SELLAS Life Sciences Group's ebitda decreased from −$12.3M to −$16.0M, a change of −$3.7M. The latest reported quarter, Q3 2017, shows −$4.4M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SELLAS Life Sciences Group filings at SEC.gov ↗